Table I.
Patient number | Gender | Age (yrs) | Follow-up period (mths) | Tumour site | Maximum tumour diameter (mm) | Resected muscles | Quadriceps resections (n) | Extension strength (%) | MSTS score (%) | TESS(%) | EQ-5D(pts) |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 66 | 123 | distal | 120 | VL,TFL,BL,BS | 1 | 91.3 | 100 | 100 | 1.000 |
2 | M | 85 | 19 | proximal | 114 | RF,IP,S,TFL | 1 | 89.7 | 86.7 | 93.7 | 1.000 |
3 | M | 60 | 136 | distal | 60 | VM | 1 | 82.9 | 100 | 100 | 1.000 |
4 | M | 74 | 85 | distal | 200 | VI | 1 | 69.9 | 93.3 | 75.9 | 0.691 |
5 | F | 57 | 18 | proximal | 113 | RF | 1 | 79.4 | 100 | 100 | 1.000 |
6 | F | 66 | 60 | distal | 60 | VM | 1 | 91.2 | 86.7 | 99.1 | 0.769 |
7 | M | 75 | 45 | distal | 56 | VL,VI1/2 | 1.5 | 52.6 | 70.0 | 60.6 | 0.516 |
8 | M | 63 | 34 | distal | 81 | VM,VI1/2,S | 1.5 | 65.2 | 100 | 100 | 1.000 |
9 | M | 60 | 80 | proximal | 78 | VL,VI1/2,TFL | 1.5 | 52.2 | 86.7 | 72.0 | 0.656 |
10 | M | 34 | 124 | distal | 50 | RF,VL1/2 | 1.5 | 56.2 | 90.0 | 90.1 | 0.850 |
11 | F | 59 | 21 | proximal | 94 | RF1/2,VL,TFL | 1.5 | 32.6 | 50.0 | 89.8 | 0.796 |
12 | M | 34 | 19 | distal | 61 | VM,VI1/2 | 1.5 | 71.7 | 96.7 | 100 | 0.796 |
13 | M | 76 | 12 | proximal | 132 | RF,VL1/2,GMe1/2,S,TFL | 1.5 | 60.0 | 73.3 | 80.0 | 0.691 |
14 | M | 61 | 74 | proximal | 107 | RF,VL | 2 | 58.4 | 96.7 | 98.2 | 1.000 |
15 | M | 74 | 47 | proximal | 110 | RF,VM,VI1/2, S,G,AM,AL,AB | 2.5 | 53.3 | 70.0 | 62.5 | 0.533 |
16 | F | 73 | 73 | middle | 140 | VM,VL,VI,TFL | 3 | 24.8 | 53.3 | 86.1 | 0.631 |
17 | M | 57 | 15 | proximal | 150 | RF,VM,VL,VI,S,TFL | 4 | 0 | 73.3 | 75.0 | 0.693 |
18 | M | 50 | 12 | proximal | 100 | RF,VL1/2,VI2/3,FN,IP,S | 4 (FN) | 0 | 73.3 | 78.3 | 0.587 |
VL, vastus lateralis; TFL, tensor fasciae latae; BL, biceps femoris long head; BS, biceps femoris short head; RF, rectus femoris; IP, iliopsoas; S, sartorius; VM, vastus medialis; VI, vastus intermedius; GMe, gluteus medius; G, gracilis; AM, adductor magnus; AL, adductor longus; AB, adductor brevis; FN, femoral nerve; MSTS, Musculoskeletal Tumor Society; TESS, Toronto Extremity Salvage Score; EQ-5D, European Quality of Life-5 Dimensions